Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
DeepAIPs-Pred: Predicting Anti-Inflammatory Peptides Using Local Evolutionary Transformation Images and Structural
Shahid Akbar1,2, Matee Ullah1, Ali Raza3
1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu 610054, China.
Abstract:
Inflammation is a biological response to harmful stimuli, playing a crucial role in facilitating tissue repair by eradicating pathogenic microorganisms. However, when inflammation becomes chronic, it leads to numerous serious disorders, particularly in autoimmune diseases. Anti-inflammatory peptides (AIPs) have emerged as promising therapeutic agents due to their high specificity, potency, and low toxicity. However, identifying AIPs using traditional in vivo methods is time-consuming and expensive. Recent advancements in computational-based intelligent models for peptides have offered a cost-effective alternative for identifying various inflammatory diseases, owing to their selectivity toward targeted cells with low side effects. In this paper, we propose a novel computational model, namely, DeepAIPs-Pred, for the accurate prediction of AIP sequences. The training samples are represented using LBP-PSSM- and LBP-SMR-based evolutionary image transformation methods. Additionally, to capture contextual semantic features, we employed attention-based ProtBERT-BFD embedding and QLC for structural features. Furthermore, differential evolution (DE)-based weighted feature integration is utilized to produce a multiview feature vector. The SMOTE-Tomek Links are introduced to address the class imbalance problem, and a two-layer feature selection technique is proposed to reduce and select the optimal features. Finally, the novel self-normalized bidirectional temporal convolutional networks (SnBiTCN) are trained using optimal features, achieving a significant predictive accuracy of 94.92% and an AUC of 0.97. The generalization of our proposed model is validated using two independent datasets, demonstrating higher performance with the improvement of ∼2 and ∼10% of accuracies than the existing state-of-the-art model using Ind-I and Ind-II, respectively. The efficacy and reliability of DeepAIPs-Pred highlight its potential as a valuable and promising tool for drug development and research academia.

